Sun feels heat of 'surprise' FDA scrutiny
This article was originally published in Scrip
Executive Summary
Sun Pharmaceutical Industries was among the top losers on Indian bourses on 11 September after reports suggested that one of its manufacturing sites may be in the midst of a surprise inspection by the US FDA.